VERA
Vera Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.92 / 10
Netural
Analyst sentiment is bullish, with one Strong Buy and one Buy covering 100% of recommendations, though historical win rates vary. Fund‑flow score is 7.83/10, showing strong inflows across most investor sizes except medium‑scale. Overall positive capital interest.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-11
InstitutionWolfe Research
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for VERA?
- VERA holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.92/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
